HRMY
Harmony Biosciences Holdings, Inc.
A biopharmaceutical company in Plymouth Meeting, Pennsylvania, that makes WAKIX (pitolisant), a medication for narcolepsy that helps people with the sleep disorder stay awake and controls sudden muscle weakness (cataplexy). Founded in 2017 by Paragon Biosciences, the company licensed the drug's U.S. rights from the French firm Bioprojet. The brand name WAKIX is a play on the word "wake," and unlike many narcolepsy treatments, it is not a controlled substance.
CUSIP: 413197104HealthcareUS1 holder
Total Value
$9.05M
Total Shares
248.6K
Net Share Change
-2.9K
Activity
1 selling
Investor
Value
Shares
Weight
Change
